74 products having the ‘Silent War’ in the shingles treatment market
A number of domestic pharmaceutical companies entered and competed in the shingles treatment ‘Famciclovir’ market.
Since Novartis Korea introduced the product in Korea in 2001, its 73 generic products have been approved, becoming the common product that every company must have.
As its patent is...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
